Cartesian Therapeutics
RNAC
RNAC
83 hedge funds and large institutions have $43.9M invested in Cartesian Therapeutics in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18% more capital invested
Capital invested by funds: $37.2M → $43.9M (+$6.71M)
7.13% more ownership
Funds ownership: 19.85% → 26.98% (+7.1%)
Holders
83
Holding in Top 10
–
Calls
$6K
Puts
$3K
Top Buyers
| 1 | +$15.8M | |
| 2 | +$855K | |
| 3 | +$599K | |
| 4 |
Two Sigma Investments
New York
|
+$542K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$520K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$815K | |
| 3 | -$557K | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
-$356K |
| 5 |
Walleye Capital
New York
|
-$316K |
